What is Current Surgical?
Current Surgical operates as a specialized medtech entity and medical device manufacturer. The company focuses on the intersection of advanced engineering and clinical application, aiming to refine surgical precision through innovative hardware solutions. By maintaining a headquarters in Washington, D.C., the firm benefits from proximity to regulatory hubs and healthcare policy centers, which is essential for navigating the complex landscape of medical device commercialization. Their market position is defined by a commitment to high-fidelity surgical tools that address critical gaps in current procedural workflows, thereby enhancing patient outcomes and operational efficiency for healthcare providers.
How much funding has Current Surgical raised?
Current Surgical has raised a total of $3.2M across 1 funding round:
Angel/Seed
$3.2M
Angel/Seed (2023): $3.2M with participation from True Ventures and 1517 Fund I
Key Investors in Current Surgical
True Ventures
True Ventures is a founder-first venture capital firm that partners with creative teams at the earliest stages, providing capital, guidance, and a strong community to help build enduring technology and artificial intelligence-driven companies.
1517 Fund I
1517 Fund is a venture capital and private equity firm specializing in pre-seed and seed investments, established in 2015 and based in San Francisco, California.
What's next for Current Surgical?
With the infusion of this recent capital, Current Surgical is expected to scale its manufacturing capabilities and expand its clinical trial footprint. The strategic roadmap likely involves deepening its intellectual property portfolio and securing necessary regulatory clearances to bring its flagship devices to market. As the company matures, the focus will shift toward commercialization strategies and establishing partnerships with major hospital networks. This growth trajectory suggests a transition toward Series A or B financing rounds, as the firm seeks to solidify its market share in the competitive medical device sector while maintaining its focus on technological innovation and clinical efficacy.
See full Current Surgical company page
